NCT05687357View on ClinicalTrials.gov

Tislelizumab in Combination With Pre-operative CRT Versus SOC for Locally Advanced G/GEJ Adenocarcinoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

March 15, 2023

Primary Completion Date

February 28, 2027

Study Completion Date

August 31, 2027

Conditions
Gastric CancerGastroesophageal-junction Cancer
Interventions
DRUG

Tislelizumab

IV infusion

DRUG

S-1

Oral tablets

DRUG

Oxaliplatin

IV infusion

DRUG

Nab paclitaxel

IV infusion

RADIATION

Radiation

TOMO/VMAT

Trial Locations (3)

Unknown

NOT_YET_RECRUITING

Wuhan Tongji Hospital, Wuhan

RECRUITING

Nanjing Drum Tower Hospital, Nanjing

NOT_YET_RECRUITING

Shanxi Province Cancer Hospital, Taiyuan

All Listed Sponsors
lead

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER